| Clinical data | |
|---|---|
| Other names | 4-Phenylbut-3-yn-2-amine; PAL-874; PAL874 |
| Drug class | Norepinephrine–dopamine releasing agent[1] |
| Identifiers | |
| |
| PubChemCID | |
| ChemSpider | |
| Chemical and physical data | |
| Formula | C10H11N |
| Molar mass | 145.205 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Phenylbutynamine (4-phenylbut-3-yn-2-amine; development codePAL-874) is amonoamine releasing agent (MRA) of thearylalkylamine family related toβ-phenethylamine andamphetamine.[1] It acts as anorepinephrine–dopamine releasing agent (NDRA), albeit with far lowerpotency than β-phenethylamine or amphetamine.[1][2]
Thispsychoactive drug-related article is astub. You can help Wikipedia byexpanding it. |